Lenalidomide Cipla 10 mg kapseli, kova Suomi - suomi - Fimea (Suomen lääkevirasto)

lenalidomide cipla 10 mg kapseli, kova

cipla europe nv - lenalidomide - kapseli, kova - 10 mg - lenalidomidi

Lenalidomide Cipla 5 mg kapseli, kova Suomi - suomi - Fimea (Suomen lääkevirasto)

lenalidomide cipla 5 mg kapseli, kova

cipla europe nv - lenalidomide - kapseli, kova - 5 mg - lenalidomidi

Lenalidomide Accord Euroopan unioni - suomi - EMA (European Medicines Agency)

lenalidomide accord

accord healthcare s.l.u. - lenalidomidi - multiple myeloma - immunosuppressantit - multiple myelomalenalidomide accord as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide accord as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) on tarkoitettu aikuisille potilaille, joilla on aiemmin hoitamaton multippeli myelooma, jotka eivät ole oikeutettuja siirto. lenalidomidin accord yhdistelmänä deksametasonin kanssa on tarkoitettu hoitoon multippelia myeloomaa sairastaville aikuispotilaille, jotka ovat saaneet vähintään yhtä aiempaa hoitoa. follicular lymphomalenalidomide accord in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a).

Lenalidomide Mylan Euroopan unioni - suomi - EMA (European Medicines Agency)

lenalidomide mylan

mylan ireland limited - lenalidomidi - multiple myeloma - immunosuppressantit - multiple myelomalenalidomide mylan as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide mylan as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone is indicated for the treatment of adult patients with previously untreated multiple myeloma who are not eligible for transplant. lenalidomide mylan in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. follicular lymphomalenalidomide mylan in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1-3a).

Lenalidomide Ratiopharm 2.5 mg kapseli, kova Suomi - suomi - Fimea (Suomen lääkevirasto)

lenalidomide ratiopharm 2.5 mg kapseli, kova

teva b.v. - lenalidomidin hydrochloride hydraatti - kapseli, kova - 2.5 mg - lenalidomidi

Lenalidomide Ratiopharm 5 mg kapseli, kova Suomi - suomi - Fimea (Suomen lääkevirasto)

lenalidomide ratiopharm 5 mg kapseli, kova

teva b.v. - lenalidomidin hydrochloride hydraatti - kapseli, kova - 5 mg - lenalidomidi

Lenalidomide Ratiopharm 7.5 mg kapseli, kova Suomi - suomi - Fimea (Suomen lääkevirasto)

lenalidomide ratiopharm 7.5 mg kapseli, kova

teva b.v. - lenalidomidin hydrochloride hydraatti - kapseli, kova - 7.5 mg - lenalidomidi

Lenalidomide Ratiopharm 10 mg kapseli, kova Suomi - suomi - Fimea (Suomen lääkevirasto)

lenalidomide ratiopharm 10 mg kapseli, kova

teva b.v. - lenalidomidin hydrochloride hydraatti - kapseli, kova - 10 mg - lenalidomidi

Lenalidomide Ratiopharm 15 mg kapseli, kova Suomi - suomi - Fimea (Suomen lääkevirasto)

lenalidomide ratiopharm 15 mg kapseli, kova

teva b.v. - lenalidomidin hydrochloride hydraatti - kapseli, kova - 15 mg - lenalidomidi

Lenalidomide Ratiopharm 20 mg kapseli, kova Suomi - suomi - Fimea (Suomen lääkevirasto)

lenalidomide ratiopharm 20 mg kapseli, kova

teva b.v. - lenalidomidin hydrochloride hydraatti - kapseli, kova - 20 mg - lenalidomidi